By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301



Company News
Innovus Pharma Launches Allervarx, A Clinically Proven Supplement For The Relief Of Allergy Symptoms, In The United States 5/24/2017 7:40:45 AM
Innovus Pharma Files Its Product License Application In Canada For The Commercialization Of Vesele As A Natural Health Product To Help Improve Symptoms Of Sexual Dysfunction 5/18/2017 9:22:21 AM
Innovus Pharma Signs Exclusive License And Distribution Agreement With Densmore For Zestra In France And Belgium For Female Sexual Arousal Disorder 5/16/2017 8:28:58 AM
Innovus Pharma Reports Quarterly Revenue For The First Quarter 2017 Of $2.2 Million 5/15/2017 7:33:19 AM
Innovus Pharma Announces Commercial Partnership To Launch FlutiCare Under FDA Approved ANDA No. 207957 5/9/2017 6:20:50 AM
Innovus Pharma To Release First Quarter 2017 Financial Results And Provide Corporate Update On Friday, May 12, 2017 5/3/2017 9:02:38 AM
Innovus Pharma Launches ProstaGorx Product For Prostate Health Through Its Beyond Human Sales And Marketing Platform In The United States 5/1/2017 9:07:08 AM
Innovus Pharma Receives Patent For Its Sensum+ Product In Morocco 4/12/2017 7:10:28 AM
Innovus Pharma Announces Receipt Of Notification To Commercialize Zestra Glide In The European Union 4/5/2017 7:54:44 AM
Innovus Pharma Announces Receipt Of Notice Of Intention To Grant Sensum+ European Patent 3/27/2017 6:26:25 AM